Crazy stock! Nothing in early/pre-trade, now finding more and more support.Jeans-sammy, you're usually spot-on with your posts, so I'm looking forward to seeing it pushing back up over 30 :-)
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%